Severity
Critical
FDA Drug recall · Reported December 28, 2016
Non-Sterility: failed sterility test result.
Guardian Pharmacy Services recalled Lidocaine HCL/ Sodium Bicarb, 1%/0.5% 0.5 mL SYR PF, packaged in a 3 cc pre-filled syring… - a critical-severity action.
Lidocaine HCL/ Sodium Bicarb, 1%/0.5% 0.5 mL SYR PF, packaged in a 3 cc pre-filled syring… was recalled by Guardian Pharmacy Services in December 28, 2016. Reason: Non-Sterility: failed sterility test result.. Check the official notice for the remedy. Verify recall #D-0211-2017 with the FDA Drug before acting.
The recall
Guardian Pharmacy Services issued this critical-severity FDA Drug recall-Non-Sterility: failed sterility test result..
Sourced from official FDA Drug enforcement records. Verify recall #D-0211-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0211-2017) was formally reported on December 28, 2016, with the manufacturer initiating the action on September 23, 2016. It is classified under Critical severity (Class I), with a current status of Terminated. Guardian Pharmacy Services is listed as the recalling firm, operating out of Dallas, TX. Federal records list the affected scope as 180 syringes.
The documented reason for this recall is: Non-Sterility: failed sterility test result. Distribution data in the federal record shows the product reached: Two medical facilities in TX. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
180 syringes
Related Recalls
6
0 from same agency
Lidocaine HCL/ Sodium Bicarb, 1%/0.5% 0.5 mL SYR PF, packaged in a 3 cc pre-filled syringe, Rx only
Non-Sterility: failed sterility test result.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0211-2017 |
| Date reported | December 28, 2016 |
| Date initiated | September 23, 2016 |
| Recalling firm | Guardian Pharmacy Services |
| Firm location | Dallas, TX |
| Affected scope | 180 syringes |
| Distribution | Two medical facilities in TX |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 28, 2016. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.